FDA Approved: EDECRIN — Supplemental Application (Bausch Health US, LLC)

View source ↗

Summary

FDA approved a supplemental application for EDECRIN (ethacrynic acid) submitted by Bausch Health US, LLC, updating the drug's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Edema
• Heart Failure
• Hepatic Cirrhosis
• Nephrotic Syndrome
• Pulmonary Edema

Drugs mentioned

• EDECRIN (Ethacrynic acid)

Snippet

SUPPL AP for EDECRIN (ETHACRYNIC ACID)